4D Molecular Therapeutics, Inc.

NASDAQ:FDMT

8.28 (USD) • At close November 7, 2024
Overview | Financials

Numbers are in millions (except for per share data and ratios) USD.

2024 Q22024 Q12023 Q42023 Q32023 Q22023 Q12022 Q42022 Q32022 Q22022 Q12021 Q42021 Q32021 Q22021 Q12020 Q42020 Q32020 Q12019 Q42019 Q32019 Q22019 Q12018 Q42018 Q32018 Q1
Assets:
Current Assets:
Cash & Cash Equivalents 189.061275.594249.108275.678310.343201.85952.351108.298113.48475.97153.00190.989243.743259.865276.72688.755-49.65249.652-72.86972.86972.86991.76191.761-23.85
Short Term Investments 352.885250.31739.12443.98674.032121.885161.203119.417127.604160.18394.77670.686000099.3040145.738000047.7
Cash and Short Term Investments 541.946525.911288.232319.664310.343201.859213.554227.715241.088236.153247.777161.675243.743259.865276.72688.75549.65249.65272.86972.86972.86991.76191.76123.85
Net Receivables 0000000.70000.0470.7911.2180.9651.4860.89600.97801.1611.1611.1241.1240
Inventory 000000-0.700000000000000000
Other Current Assets 10.6879.6788.3568.5797.4336.5866.9574.7635.4356.8948.4563.2673.7913.6714.4442.88501.87801.4151.4151.1831.1830
Total Current Assets 552.633535.589296.588328.243310.343207.04220.511232.478246.523243.047256.28165.733248.752264.501282.65692.53649.65252.50872.86975.44575.44594.06894.06823.85
Non-Current Assets:
Property, Plant & Equipment, Net 29.44930.58231.66532.68833.64734.31635.34735.51134.91832.64228.9538.7895.585.0115.0734.98105.04904.0264.0262.4722.4720
Goodwill 000000000000000000000000
Intangible Assets 000000000000000000000000
Goodwill and Intangible Assets 000000000000000000000000
Long Term Investments 35.71562.94210.954001.4054.90811.12220.53248.36267.65265.494000000000000
Tax Assets 000000000000000000000000
Other Non-Current Assets 2.320.7710.6840.6828.5131.261.081.0530.9630.8750.6020.6020.6020.6020.6020.675-49.6520.677-72.8691.0291.0290.4290.429-23.85
Total Non-Current Assets 67.48494.29543.30333.3742.1636.98141.33547.68656.41381.87997.20774.8856.1825.6135.6755.656-49.6525.726-72.8695.0555.0552.9012.901-23.85
Total Assets 620.117629.884339.891361.613352.503244.021261.846280.164302.936324.926353.487240.618254.934270.114288.33198.192058.234080.580.596.96996.9690
Liabilities & Equity:
Current Liabilities:
Account Payables 3.4314.2173.5154.7133.4932.4083.3221.483.3162.6814.7643.7131.9621.2841.7871.29201.74401.1151.1150.9540.9540
Short Term Debt 3.1963.1733.1493.1263.1032.6782.6552.6332.5962.0371.231000000000.18100.09300
Tax Payables 00000000000000000000.18100.09300
Deferred Revenue 1.3181.3220.2730.130.5760.7780.8842.2072.2562.1092.5991.7283.0167.0876.5865.61905.86404.24604.90700
Other Current Liabilities 11.4587.69112.01410.1946.5775.4148.877.2446.1635.2647.7445.9324.8925.5458.3717.36705.34703.0617.4882.17.10
Total Current Liabilities 19.40316.40318.95118.16313.74911.27815.73113.56414.33112.09116.33811.3739.8713.91616.74414.278012.95508.6038.6038.0548.0540
Non-Current Liabilities:
Long Term Debt 10.4610.99811.52212.03112.52713.00513.46913.91914.40214.78215.2170000000000000
Deferred Revenue Non-Current 1.3181.3220.9721.0960.8470.8841.0761.0011.4521.7612.4913.012.34211.6913.22611.731013.603010.777013.07600
Deferred Tax Liabilities Non-Current 000.3690.3690.2120000000000000000000
Other Non-Current Liabilities 0.5960.60.2480.020.0240.2480.2330.2360.2340.2360.3342.1012.0762.0771.9742.0270104.6460103.4240103.42600
Total Non-Current Liabilities 12.37412.9213.11113.51613.6114.13714.77815.15616.08816.77918.0425.1114.41813.76715.213.7580118.2490114.2010116.50200
Total Liabilities 31.77729.32332.06231.679725.29125.41530.50928.7230.41928.8734.3816.48414.28827.68331.94428.0360131.2040122.8048.603124.5568.0540
Equity:
Preferred Stock 000000000000000175.448102.98102.98102.98102.98102.98102.98102.9818.508
Common Stock 0.0050.0050.0040.0040.0040.0030.0030.0030.0030.0030.0030.0030.0030.0030.0030.00200.00100.0010.0010.0010.0010
Retained Earnings -482.681-447.728-415.327-383.044-372.788-343.172-314.49-287.111-261.42-233.334-206.996-181.913-159.674-152.085-135.679-115.1320-79.0250-46.235-46.235-30.026-30.0260
Accumulated Other Comprehensive Income/Loss -0.293-0.1090.0160.5340.345-0.27-1.196-1.851-1.827-1.421-0.423-0.195000-175.448-72.97-102.98-42.304-102.980-102.980-19.59
Other Total Stockholders Equity 1,071.3091,048.393723.136712.44-0.3490.267547.02540.403535.761530.808526.523406.239400.317394.513392.063185.28606.05403.933.932.4382.4380
Total Shareholders Equity 588.34600.561307.829329.934-372.788-343.172231.337251.444272.517296.056319.107224.134240.646242.431256.38770.15630.01-72.9760.676-42.30460.676-27.58775.393-1.082
Total Equity 588.34600.561307.829329.934-372.788-343.172231.337251.444272.517296.056319.107224.134240.646242.431256.38770.15630.01-72.9760.676-42.30460.676-27.58775.393-1.082
Total Liabilities & Shareholders Equity 620.117629.884339.891361.613352.503-317.757261.846280.164302.936324.926353.487240.618254.934270.114288.33198.19230.0158.23460.67680.569.27996.96983.447-1.082